São Pedro da Aldeia adota nova estratégia de proteção para bebês contra vírus respiratório
The municipality of São Pedro da Aldeia, Brazil, is adopting a new SUS health strategy using the monoclonal antibody nirsevimabe to protect vulnerable infants against Respiratory Syncytial Virus (RSV). The initiative targets premature newborns and children under two with high-risk health conditions to reduce severe bronchiolitis cases and hospitalizations.
RSV nirsevimabe infant health bronchiolitis Brazil